{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-22-009401","form_type":"8-K","ticker":"CELZ","cik":"0001187953","company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","filed_at":"2022-12-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.849643+00:00","generated_at":"2026-06-21T02:23:35.233152+00:00","sec_items":["5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Creative Medical Technology shareholders elect all directors, approve executive compensation and auditor ratification","bullets":["Seven directors elected with votes ranging from 2,675,852 to 2,694,252 in favor; no withhold above 361,796.","Executive compensation approved with 2,422,079 for, 588,661 against, 26,908 abstain, 4,818,286 broker non-votes.","Advisory vote on executive compensation set to every one year, approved with 2,854,354 for one year.","Ratification of Haynie & Company as auditor approved with 7,690,484 for, 144,871 against, 20,579 abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-22-009401","json":"https://secwatch.observer/filing/0001477932-22-009401.json","markdown":"https://secwatch.observer/filing/0001477932-22-009401.md","text":"https://secwatch.observer/filing/0001477932-22-009401.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1187953/000147793222009401/0001477932-22-009401-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1187953/000147793222009401/celz_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T02:23:35.233152+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6503fe7d1ca3d4a2bccbb8d737b3faff0734cbdc","claim":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. shareholders approved Approval of the compensation of the Company's named executive officers at the 2022-12-19 meeting.","evidence_excerpt":"Proposal II - The compensation of the Company’s named executive officers was approved as follows: For Against Abstain Broker Non-Votes 2,422,079 588,661 26,908 4,818,286","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1187953/000147793222009401/0001477932-22-009401-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-19"}],"fact_type":"shareholder_vote"},{"claim_id":"7a3a03f1d5f50971250e74f527350bc55778aa75","claim":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. shareholders approved Election of the five director nominees named in the Proxy Statement at the 2022-12-19 meeting.","evidence_excerpt":"The five director nominees were all elected to the Board as follows: Director For Withhold Timothy Warbington 2,694,252 343,196 Donald Dickerson 2,693,855 343,793 Michael H. Finger 2,675,852 361,796 Susan Snow 2,690,084 347,564 Bruce S. Urdang, Esq. 2,677,918 359,730","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1187953/000147793222009401/0001477932-22-009401-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-19"}],"fact_type":"shareholder_vote"},{"claim_id":"c32c76cb1b64c157af51f953fea8ed8ba7e94e26","claim":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. shareholders approved Ratification of appointment of Haynie & Company as independent registered public accountants at the 2022-12-19 meeting.","evidence_excerpt":"Proposal IV - The ratification of the appointment of Haynie & Company was approved as follows: For Against Abstain Broker Non-Votes 7,690,484 144,871 20,579 N/A","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1187953/000147793222009401/0001477932-22-009401-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-19"}],"fact_type":"shareholder_vote"},{"claim_id":"df830a7aa4b5112aca13d57d800838fed6839233","claim":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. shareholders approved Advisory vote on frequency of executive compensation votes at the 2022-12-19 meeting.","evidence_excerpt":"Proposal III – Holding an advisory vote on executive compensation on an annual basis was approved as follows: One Year Two Years Three Years Abstain Broker Non-Votes 2,854,354 33,493 116,755 33,046 4,818,286","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1187953/000147793222009401/0001477932-22-009401-index.htm","confidence":1.0,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay frequency"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2022-12-19"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}